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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?response could not be 
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ ? ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
A test result where a normal  ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
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Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
BAPM   British Association of Perinatal Medicine   
BIOS  British and Irish Orthoptics Society  
CCG  Clinical Commissioning Group 
GDG   Guideline Development Group  
GDP   Gross Domestic Product 
GP  General Practitioner 
LA   Local Authority  
NHS  National Health Service 
NICU  Neonatal-intensive care unit 
NIPE   Newborn and Infant Physical Examination 
NSC   National Screening Committee  
ONS  Office of National Statistics 
PHE   Public Health England  
PPP   Purchasing Power Parity 
RCOphth  Royal College of Ophthalmologists 
RCPCH  Royal College of Paediatrics & Child Health  
ROP  Retinopathy of Prematurity 
SIG  Special Interest Group 
UK  United Kingdom 
VA   Visual Acuity  
WHO   World Health Organisation 
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3 Population and Healthcare Overview 
The population of the United Kingdom (UK), including England, Wales, Scotland and 
Northern Ireland, is estimated at 66,022,273 (World Bank, 2018a) and the birth rate in 2016 
was estimated at 11.8 births/1,000 population (World Bank, 2018b).  
In 2017, England had a reported population of 55,619,400 and Wales had a reported 
population of 3,125,200 (McMullan, 2018). The UK has a reported population density of 
272.90 people per square kilometre (World Bank, 2018c). When considering England alone 
this is 427 people per square kilometre and 151 in Wales (Statista, 2018). Infant mortality in 
the UK as a whole, is estimated at 3.7 deaths/1,000 live births (World Bank, 2018d).  
The average life expectancy in the whole of the UK is estimated to be 81 years (World Bank, 
2018e), with a death rate of 9.1 deaths/1,000 population in 2016 (World Bank, 2018f).  
Between 2012 and 2014, the average life expectancy in England was estimated as 80 for 
men and 83 for women; in Wales it was 79 for men and 82 for women (Ons.gov.uk, 2018).  
The UK has a gross national income per capita (Purchasing Power Parity - PPP int. $, 2013) 
of $35,000 (WHO, 2016). The estimated total expenditure on health per capita in 2014 was 
$3,377 (Intl $) and the total expenditure on health as percentage of GDP was 9.1% in 2014 
(WHO, 2016). 
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Figure 1: Change in the Total Population and Birth Rate in the United Kingdom between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
Summary Vision Screening Data: England & Wales                                                                         
 
3 
 
4 Vision Screening Commissioning and Guidance 
In England and Wales, vision screening is organised either nationally or regionally, depending 
on the type of screening. Premature babies are screened through a service commissioned by 
local Clinical Commissioning Groups (CCGs). CCGs are clinically led, statutory National Health 
Service (NHS) bodies responsible for the planning and commissioning of health care services 
for their local area. There are now 195 CCGs in England. They assess local needs, decide 
priorities and strategies, and then buy services on behalf of the population from providers 
such as hospitals, clinics or community health bodies. Screening of all babies is commissioned 
by a national programme through Public Health England (PHE). This is a standardised 
programme with a national specification and national monitoring of standards. Screening for 
reduced vision is organised regionally by each Local Authority (LA), although not all regions 
provide this recommended vision screening. Mapping of services throughout the UK was 
completed by the British and Irish Orthoptic Society (BIOS) in 2014, these maps show areas 
that do not offer visual acuity screening (Appendix 1  ? Vision Screening Map B). There have 
been some changes to these services over the last 4 years but there is no ongoing system in 
place to record these changes.  
Despite UK National Screening Committee (NSC) recommendations for screening to test visual 
acuity (VA) at age 4 to 5 years being in existence since 2003 (GOV.UK, 2018d), there are 
differences in vision screening protocols for reduced vision between regions, concerning the 
professionals who conduct screening, the age screened, the tests used, referral criteria, 
referral pathways and the funding. Visual acuity screening should be ĨƵŶĚĞĚďǇĞĂĐŚƌĞŐŝŽŶ ?Ɛ
LA. The content of the programme is decided upon by a LA, based on individual service 
specifications. To address these differences PHE produced national guidance and 
specifications for visual acuity screening at age 4 to 5 years in November 2017 (described 
more fully in section 3 below). But as this screening is not mandatory, LAs may not adopt 
these guidelines. It is too early to evaluate whether this guidance has led, or will, lead to 
improved standardisation and equity in service provision. 
The National Newborn Infant Physical Examination (NIPE), which includes screening of the 
eyes, was implemented in its current form in 2008. Revisions to the recommendation are 
made by the NSC and funded by the Government Department of Health. Revisions take place 
based on published evidence and review by the committee and experts. Quality monitoring 
is imposed by the government using standards devised by experts for PHE; these were last 
updated in August 2018 (GOV.UK, 2018b). 
For visual acuity screening, it is not known when each of these services was implemented as 
services vary across the country. The UK NSC first recommended screening for visual acuity 
at age 4 to 5 years of age in 2003. A review of evidence was carried out in 2013 and the 
recommendations were reapproved at that stage. A review of evidence and revision to the 
recommendation by the UK NSC is expected in 2019. Revisions to the recommendation made 
by the NSC are funded by the Government via the Department of Health. Revisions take place 
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based on published evidence and review by a committee and experts. Currently there are no 
methods for quality monitoring imposed by the government and quality assurance is dictated 
by service agreements of the LA with service providers, which are usually hospital orthoptic 
departments. PHE have commissioned development of standards to advise the LA and to 
standardise the approach taken to this. 
There have been surveys for mapping and collection of outcome data conducted, regarding 
the screening programmes across the UK, by the British and Irish Orthoptic Society (BIOS) 
(Griffiths, Carlton and Mazzone, 2017; Griffiths, Carlton and Mazzone, 2018) and private 
companies investigating automated screening. There has also been a cost-effectiveness 
analysis (Carlton et al., 2008). Local department audits have been conducted to determine 
the effectiveness of the vision screening programme in the UK.  It is not known how many 
vision screening professionals there are in the UK per million population. Nurses, Healthcare 
Assistants and Orthoptic Assistants conduct screening in some areas, no other general 
healthcare professionals have been identified that do not screen, but could do so with 
additional training. There is specific training to perform vision screening, this is usually 
completed by non-eye health professions using an official training package, such as the BIOS 
training tool. This training can take between 1-4 months to complete, but it is dependent on 
the individual. Competency assessments, quality assurance and training updates take place 
annually, however, this training is not accredited or certified; it is agreed ad-hoc by the 
provider and commissioners of each service and has been adapted to local packages in some 
case. PHE has commissioned a standardised training package based on the BIOS training. This 
will be available in 2019. 
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5 Screening programme  
The target conditions screened for in England and Wales are: 
භ Retinopathy of prematurity (ROP) 
භ Congenital eye disorders at birth - primarily congenital cataracts but also any 
additional risk factors for eye disease or other incidental findings, for example, 
aniridia, coloboma and retinoblastoma  
භ Reduced vision at the age of 4 to 5 years of age, specifically due to amblyopia but may 
also include uncorrected refractive error 
There are evidence-based guidelines for the screening and treatment of ROP. There were 
developed in 2008 (RCOphth, 2018) by a multidisciplinary guideline development group 
(GDG) of the Royal College of Paediatrics & Child Health (RCPCH) in collaboration with the 
Royal College of Ophthalmologists (RCOphth), British Association of Perinatal Medicine 
(BAPM) and the premature baby charity BLISS. It provides 25 evidence-based 
recommendations and 21 good practice points. This guideline has been produced specifically 
for use within the UK and supersedes a previous guideline.  
Vision screening in well health babies is combined with a general screening programme (NIPE) 
(GOV.UK, 2018c).  The UK NSC recommends that all eligible babies should be offered the NIPE 
screen. The screen is undertaken and completed within 72 hours of birth and then again at 6 
to 8 weeks of age. The NHS NIPE Screening Programme aims to reduce morbidity and 
mortality by: 
භ identifying and referring all children born with congenital abnormalities of the eyes, 
heart, hips, and testes, where these are detectable, within 72 hours of birth 
භ identifying those abnormalities that may become detectable by 6 to 8 weeks of age, 
at the second physical examination 
The UK NSC (2013) continues to recommend vision screening for reduced vision at the age of 
4 to 5 years offered by an Orthoptic-led service and provided by Local Authorities as part of 
the Healthy Child Programme (GOV.UK, 2018a). Public Health England (PHE) produced 
guidance in 2017 to support Local Authorities in commissioning this recommendation 
(GOV.UK, 2018d). This guidance includes a service specification, screening competencies for 
personnel delivering screening, a screening pathway including referral criteria, information 
leaflets for parents and teachers and letters to invite and inform parents.  
The health care professionals delivering vision screening, venue for screening and tests used 
vary depending on the age of the child as shown in Tables 1, 2 and 3 respectively. Specific 
details of the screening offered within each age group are described more fully in sections 5.1 
to 5.4 below. 
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5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in a neonatal 
ward or in the ophthalmology outpatient department of a hospital following the Royal College 
of Ophthalmologists guidelines (RCOphth, 2018). The tests conducted at this age include eye 
inspection and retinal examination. The sequence of these tests is:  
Ɣ ĂďŝĞƐďŽƌŶďĞĨŽƌĞ ? ?ǁĞĞŬƐ ?ŐĞƐƚĂƚŝŽŶĂůĂŐĞ ?ŝ ?Ğ ?ƵƉƚŽ ? ?ǁĞĞŬƐĂŶĚ ?days) - the 
ĨŝƌƐƚ ZKW ƐĐƌĞĞŶŝŶŐ ĞǆĂŵŝŶĂƚŝŽŶ ƐŚŽƵůĚ ďĞ ƵŶĚĞƌƚĂŬĞŶ Ăƚ  ? ? ƚŽ  ? ? ǁĞĞŬƐ ?
postmenstrual age 
Ɣ ĂďŝĞƐďŽƌŶďĞƚǁĞĞŶ ? ?ĂŶĚ ? ?ǁĞĞŬƐ ?ŐĞƐƚĂƚŝŽŶĂůĂŐĞ ?ŝ ?Ğ ?ƵƉƚŽ ? ?ǁĞĞŬƐĂŶĚ ?ĚĂǇƐ ?
- the first ROP screening examination should be undertaken between 4 to 5 weeks (i.e. 
28-35 days) postnatal age. 
Ɣ ĂďŝĞƐA? ? ?ǁĞĞŬƐ ?ŐĞƐƚĂƚŝŽŶĂůĂŐĞďƵƚǁŝƚŚďŝƌƚŚǁĞŝŐŚƚA? ? ? ? ?ŐƌĂŵƐ ? the first ROP 
screening examination should be undertaken between 4 to 5 weeks (i.e. 28-35 days) 
postnatal age. 
Ɣ Minimum frequencies of screening should be weekly when: 
o the vessels end in zone I or posterior zone II; or 
o there is any plus or pre-plus disease or 
o there is any stage 3 disease in any zone. 
Ɣ Minimum frequencies of screening should be every 2 weeks: 
o In all other circumstances until the criteria for termination have been 
reached. 
Ɣ All babies <32 weeks gestational age or birth weight <1501g should have 
their first ROP screening examination prior to discharge. 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician or a specialist 
nurse in a hospital or at the home of the child. The tests conducted at this age include eye 
inspection, fixation, red reflex testing, eye motility, pursuit movements and pupillary reflexes. 
Fundus red reflex examination to diagnose a white pupil is performed only by the 
paediatrician. The sequence of these tests is:  
Ɣ Within the first 72 hours from birth: Eye opening, presence of eyes, position and 
symmetry, size and colour, presence of red reflex. 
Ɣ Repeated between 6-8 weeks from birth: As above with the addition of eye motility 
and fixing and following. 
Babies are referred after one failed screening tests, however there is no definition as to how 
many inconclusive tests necessitate referral for further diagnostic examination. 
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5.3 Vision screening - 3 months to 36 months 
There is no population-based vision screening recommended by PHE in this age group. 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years of age are screened once at age 4 to 5 years. There are 
no guidelines or recommendations for children in other age groups to receive vision 
screening.  
The screening is delivered by either a school nurse, healthcare assistant, orthoptic assistant 
or an orthoptist, this varies depending on the area and the contract agreed by the LA.  
In most areas the vision screening takes place in schools but rarely it may take place in hospital 
clinics or community clinics.  
The UK PHE recommended test to be conducted at age 4 to 5 years is a visual acuity 
measurement with the Keeler Crowded logMAR test and this is used in most areas. Some 
areas use Sheridan Gardiner singles test (Snellen), Kay Pictures (single or crowded depending 
on co-operation and ability) or Sonksen Silver crowded logMAR test.  
The PHE guidance is that any child not achieving 0.2 logMAR on the Keeler Crowded logMAR 
test should be referred after one screen even if it is suspected to be due to poor cooperation. 
In some areas the vision screening offered varies from the UK NSC and PHE recommendation 
as follows: 
Not all areas receive primary vision screening (Appendix 1 - Vision Screening Map A). Some 
areas commission screening at pre-school aged 3 years (Appendix 1 - Vision Screening Map 
C). Some areas provide visual acuity and an orthoptic assessment; this includes cover test, 
ocular movements, convergence, stereotests (Frisby test), prism reflex test (Appendix 1 - 
Vision Screening Map B) and in rare cases includes automated screening. Some areas have a 
local arrangement to routinely offer a second screening prior to referral, for those children 
who fail the test.  The number of inconclusive results prior to referral may also differ based 
on the area.  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Ophthalmologist Orthoptist Specialist nurse Doctor Orthoptic/Healthcare 
assistant 
Preterm babies  
 
9 × × × × 
0 to 3 months  × × × 
 
9 × 
3 to 36 months  × × × × × 
3 to 7 years  × 
 
9 
 
9 × 
 
9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
inspection 
Fixation Red 
reflex 
Eye 
motility 
Hirschberg Retinal 
exam 
Pursuit 
movements 
Pupillary 
reflexes 
Cover test Visual 
acuity 
Preterm 
babies  
 
9 
 
9 
 
9 
 
x 
 
x 
 
9 
 
x 
 
9 
 
x 
× 
0 to 3 
months  
 
9 
 
9 
 
9 
 
9 
 
9 × 
 
9 
 
9 
 
9 × 
3 to 36 
months  
× × × × × × × × × × 
3 to 7 
years*  
× × × × × × × × × 
 
9 
 
*: Variable screening conducted by different CCGs and LAs. Information given in the table represents the national PHE guidance.  ? This also 
applies to Table 1. Some regions carry out VA and Orthoptic assessment including cover test, ocular motility and stereoacuity. 
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Table 3: Location of vision screening for each age group  
Table 3 
GP Clinic Home Hospital Child healthcare 
centre 
School 
Preterm babies  × × 9 × × 
0 to 3 months  9 9 9 9 × 
3 to 36 months  × × × × × 
3 to 7 years  × × × 9 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. 
Automated vision screening devices are not recommended in vision screening at any age in 
the UK. A small number of LAs offer screening that include the use of automated devices, 
however, there is no further information on this. 
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7 Provision for Visually Impaired  
In England, there are 11 schools for blind or visually impaired children, the costs per child and 
the specialist support provided for children who attend mainstream primary school are not 
known. There is no information concerning Wales.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is no national data available on prevalence of amblyopia, strabismus or congenital eye 
disease in England and Wales. In a population-based cohort study of children, data were 
available for 7825 seven-year-old children. Of these 2.3% (95% CI 2.0% to 2.7%) had manifest 
strabismus, 3.6% (95% CI 3.3% to 4.1%) had past/present amblyopia, and 4.8% (95% CI 4.4% 
to 5.3%) were hypermetropic (Williams et al., 2008). Bruce et al (2016) reported, from a 
northern city population in England, that the prevalence of strabismus, defined as manifest 
esotropic, exotropic or vertical deviation, is 2.4% at age 4-5 years. The NIPE screening 
handbook (GOV.UK, 2018e) states that approximately 2 or 3 in 10,000 babies have problems 
with their eyes that require treatment. 
8.2 Coverage  
The proportion of eligible babies who received screening of the eyes within 72 hours of birth 
(coverage) is recorded by PHE. In the year from 01/04/17 to 31/03/18, they report that of 
602,364 newborn babies in England, 574,812 (95.4%) had the eye screening within 72 hours 
of birth (Gov.UK, 2018e).  
The mean coverage using pooled data across regions submitted to a BIOS national audit of 
vision screeening at age 4-5 years for the 2016-2017 academic year was 93%, with a range of 
69.7% - 99.8% between regions (Griffiths, Carlton & Mazzone, 2018). These figures relate to 
a total of 175,407 eligible children reported of whom 162,868 received vision screening 
(Griffiths, Carlton & Mazzone, 2018).   
8.3 Screening evaluation 
At 4-5 years, the mean referral rate has been determined from national data submitted from 
50 regions to the BIOS national audit. However, the data was not always complete and as 
such, some regions were excluded from further analysis due to insufficient data. Therefore, 
the number of children does not always incorporate all children in all regions. However, of 
111,295 children screened 14,508 failed (13%) and were referred for diagnostic assessment 
(Griffiths, Carlton & Mazzone, 2018). Outcome data was available for 4,060 children who 
failed screening and were referred for diagnostic testing. The percentage of true positives was 
81% and the percentage of false positives was 19% (Griffiths, Carlton & Mazzone, 2018). There 
is no data concerning the number of false negatives, true negatives, positive predictive value, 
the sensitivity or specificity of screening.  
Griffiths, Carlton & Mazzone (2018) were able to determine the mean percentage of 
diagnoses in a population of 995 children seen for diagnostic testing following failed vision 
screening at age 4-5 years:  
x The percentage of children diagnosed with refractive e
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x The percentage of children identified as having manifest strabismus only - 5% 
x The percentage of children identified as having manifest strabismus and refractive 
error - 5% 
x The percentage of children identified as having an ocular motility defect only - 2% 
x The percentage of children identified as having poor convergence only - 2% 
x The percentage of children identified as having no confirmed abnormality but needing 
review as borderline/ poor cooperation - 6% 
x The percentage of children identified as having ophthalmic pathology only (e.g. ptosis) 
- 0.45% 
x The percentage of children identified as having ophthalmic pathology with reduced 
vision - 7% 
The mean percentage of patients who required an ophthalmic opinion (n=885; N=7937) was 
approximately 11%.  The other 89% of referrals were managed by joint Orthoptist and 
Optometrist clinics (Griffiths, Carlton & Mazzone, 2018). 
8.4 Treatment success 
Optometrists and ophthalmologist prescribe glasses for children under the age of 7 years. 
Other treatment options include patching, penalisation with glasses and atropine. All eligible 
children are offered treatment, but not all receive treatment due to unattended 
appointments. No data is available concerning treatment outcomes. 
The percentage of children treated for congenital eye disorders, strabismus and amblyopia is 
unknown.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs (range) per year (37 hours per week) for vision screening professionals are:  
Ɣ Health Care Assistant Band 2: £15,516 - £17,978 (17,451  ? 20,220 Euros*) 
Ɣ Health Care Assistant / Orthoptic Assistants Band 3: £16,968 - £19,852 (19,085  ? 
22,329 Euros*) 
Ɣ School Nurse/Orthoptists Band 5: £21,909 - £28,462 (24,643  ? 32,013 Euros*) 
Ɣ School Nurse/Orthoptists Band 6 £26,302 - £35,225 (29,587  ? 39,614 Euros*) 
Ɣ The salary costs per hour can be calculated from this.  
 
The costs to train vision screening professionals from leaving secondary education to 
qualification are:  
Ɣ Orthoptist/Nurse (3 year degrees) - tuitions fees would cost £27,750 (31,208 Euros*), 
but screening would only be a small part of their overall role.  
Ɣ Healthcare assistant require NVQ/BTEC level 4 in healthcare. Approximate cost of 
£2,500 (2,811 Euros*) - variable depending on college selected. 
Ɣ The total screening costs per year and per child-per year for vision screening are not 
known.  
9.2 Cost of treatment for amblyopia 
The costs for treatment of typical patients with refractive and strabismic amblyopia including 
follow-up has been estimated based on the country representatives own hospital 
departmental pathway:  
Ɣ New Appointment tariff (Orthoptic/Optometry) = £110 (x1 visit) = £110 (123 Euros*) 
Ɣ Orthoptic only tariff = £50 (x13 visits) = £650 (731 Euros*) 
Ɣ Optometry (refraction) tariff = £186 (209 Euros*) 
Ɣ Patches = £10 (x5 boxes average) = £50 (56 Euros*) 
Ɣ Glasses voucher = average £49 (dependant on prescription) (x4) = £196 (220 Euros*) 
Ɣ Grand total = approximately £1,192 (1,340 Euros*) 
9.3 Cost of Treatment for strabismus  
The estimated costs of strabismus surgery including follow-up is £1000-£1600 (1,124  ? 1,799 
Euros*). 
9.4 Cost of treatment for cataract 
No data available.  
*Currency conversion as of 20/11/2018  
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Appendix 1 
Vision Screening Map A 
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Vision Screening Map B 
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Vision Screening Map C 
 
